| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
| 08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | US20020107398 Microbicides in crop protection |
| 08/08/2002 | US20020107392 Quinolinone derivatives |
| 08/08/2002 | US20020107275 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107263 Squaric acid derivatives |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | CA2672805A1 Pyrimidine derivatives |
| 08/08/2002 | CA2454215A1 Polymers |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228065A1 (indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| 08/07/2002 | EP1228064A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228051A1 Semicarbazone derivatives and their use as thrombopoietin mimetics |
| 08/07/2002 | EP1228044A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 08/07/2002 | EP1228041A2 Indole derivatives and their use as 5ht2a ligands |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
| 08/07/2002 | CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6429205 Anticoagulants |
| 08/01/2002 | WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059110A1 Pyrimidineamines as angiogenesis modulators |
| 08/01/2002 | WO2002059109A2 Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases |
| 08/01/2002 | WO2002059108A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059095A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002058730A2 Compositions for treatment of ocular neovascularization |
| 08/01/2002 | WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002028861A3 Methods and compounds for treating proliferative diseases |
| 08/01/2002 | US20020103384 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| 08/01/2002 | US20020103381 Useful in pharmaceutical industry, such as antiinflammatory or antiarthritic agents; solid phase synthesis; esterification of a hydroxylated solid support, treating wtih trimethylsilyldiazomethane, deprotecting |
| 08/01/2002 | US20020103247 Indole and dihydroindole derivatives |
| 08/01/2002 | US20020103245 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 08/01/2002 | US20020103243 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 08/01/2002 | US20020103235 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 08/01/2002 | US20020103208 Useful in treatment of anxiety disorders, affective disorders such as depression, psychosis and schizophrenia, Parkinson's disease |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103202 Heteroaryl-phenyl substituted factor Xa inhibitors |
| 08/01/2002 | US20020103201 Selective NPY (Y5) antagonists (triazines) |
| 08/01/2002 | US20020103198 Acylamino cyclopropane derivatives |
| 08/01/2002 | US20020103197 For use in protecting human and animal hair and skin against damaging action of UV radiation |
| 08/01/2002 | US20020103185 Pyrazole derivatives |
| 08/01/2002 | US20020103184 Cyclic malonamides as inhibitors of a beta protein production |
| 08/01/2002 | US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 08/01/2002 | US20020102608 Library of indolinone compounds for use in the treatment of cancer |
| 08/01/2002 | US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage |
| 08/01/2002 | US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2432988A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | EP1226129A1 Methods and compositions utilizing quinazolinones |
| 07/31/2002 | EP1226128A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226123A1 Cyano compounds as factor xa inhibitors |
| 07/31/2002 | EP1226122A1 Bicyclic vasopressin agonists |
| 07/31/2002 | EP1226116A1 Processes for the preparation of sumatriptan and related compounds |
| 07/31/2002 | EP1060165A4 Method for preparing n-substituted heterocyclic derivatives using a phase-transfer catalyst |
| 07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/31/2002 | CN1361770A Heteroaromatic ring compounds |
| 07/31/2002 | CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one |
| 07/31/2002 | CN1088459C 1,4-disubstituted piperazines |
| 07/30/2002 | US6426413 Inhibitors of caspases |
| 07/30/2002 | CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 07/30/2002 | CA2110806C 4-(1h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |